Physician profile
Hannah Mccarthy
NPI 1568928372
$1,982.42
in general payments reported to CMS, 2019-2025
18 companies · $990 in 2025
The $990 reported for 2025 was more than what 96% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $251 · 2023: $165 · 2024: $446 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.07 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $418.55 | 2025 | Voquezna |
| Astellas Pharma US INC | $306.74 | 2024-2025 | Veozah |
| Abbvie INC. | $215.72 | 2022-2025 | |
| Integra Lifesciences Corporation | $130.05 | 2021 | |
| Recor Medical INC | $124.06 | 2025 | Paradise Ultrasound Renal Denervation System |
| Neurocrine Biosciences, INC. | $122.02 | 2025 | |
| Shield Therapeutics INC | $100.87 | 2024-2025 | |
| Lilly USA, LLC | $100.18 | 2023-2024 | Emgality, Reyvow, Jardiance |
| Aspira Women'S Health INC | $97.20 | 2022 | |
| Biogen, INC. | $93.56 | 2025 | Zurzuvae |
| Amgen INC. | $51.62 | 2022-2024 | Otezla, Repatha |
| Therapeuticsmd, INC. | $46.06 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $44.55 | 2025 | |
| Sumitomo Pharma America, INC. | $36.77 | 2024-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $35.49 | 2022-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $22.07 | 2024 | |
| Exact Sciences Corporation | $19.99 | 2024 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $16.92 | 2023 | Koselugo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.